Literature DB >> 9514421

Prophylactic oophorectomy in colorectal carcinoma: preliminary results of a randomized, prospective trial.

T M Young-Fadok1, B G Wolff, S Nivatvongs, P P Metzger, D M Ilstrup.   

Abstract

UNLABELLED: Controversy exists regarding the role of prophylactic oophorectomy during resection for primary colorectal cancer.
PURPOSE: A prospective, randomized trial was initiated to evaluate the influence of oophorectomy on recurrence and survival in patients with Dukes Stages B and C colorectal cancer.
METHOD: Between November 1986 and March 1997, 155 patients were randomized to oophorectomy or no oophorectomy at laparotomy for resection of colorectal cancer.
RESULTS: No incidence of gross or microscopic metastatic disease to the ovary was found among 77 patients randomized to oophorectomy, in contrast to previous reports. Preliminary crude survival curves suggested a survival benefit for oophorectomy between two and three years from surgery, but Kaplan-Meier survival analysis indicated that this was not statistically significant and the benefit does not appear to persist at five years. Kaplan-Meier curves of recurrence-free survival, however, suggest a more substantial separation of the curves, with 80 percent vs. 65 percent five-year disease-free survival for oophorectomy vs. nonoophorectomy, but further patient accrual is necessary to provide sufficient statistical power.
CONCLUSIONS: Occult colorectal carcinoma metastatic to the ovaries has not been documented in this series of putative Dukes Stages B and C tumors. The possibility of a recurrence-free survival advantage emphasizes the need to continue this preliminary work.

Entities:  

Mesh:

Year:  1998        PMID: 9514421     DOI: 10.1007/bf02237479

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  13 in total

1.  Oophorectomy in primary colorectal cancer.

Authors:  A Schofield; J Pitt; G Biring; P M Dawson
Journal:  Ann R Coll Surg Engl       Date:  2001-03       Impact factor: 1.891

2.  Large solitary ovarian metastasis from colorectal cancer diagnosed by endoscopic ultrasound.

Authors:  Bhavani Moparty; Guillermo Gomez; Manoop S Bhutani
Journal:  World J Gastroenterol       Date:  2008-08-28       Impact factor: 5.742

Review 3.  Prognosis and factors affecting colorectal cancer with ovarian metastasis.

Authors:  Fangyue Zhou; Jingxin Ding
Journal:  Updates Surg       Date:  2021-02-01

4.  Ovarian transposition and metachronous ovarian metastasis in a premenopausal colorectal carcinoma patient: a case report.

Authors:  Shari Bodofsky; Sean Hong; George N Botros; Evita Sadimin; Patrick M Boland; Matthew P Deek
Journal:  J Gastrointest Oncol       Date:  2021-12

5.  Reoperation for recurrent colorectal cancer.

Authors:  Michael D Hellinger; Cesar A Santiago
Journal:  Clin Colon Rectal Surg       Date:  2006-11

6.  "Ovarian Metastases from Colorectal Cancer: Our Experience".

Authors:  Vasu Reddy Challa; Y G Basavana Goud; Poornima Rangappa; Vijayalakshmi Deshmane; K V Veerendra Kumar; B A Madhusudhana
Journal:  Indian J Surg Oncol       Date:  2014-12-27

7.  The role of chemotherapy and prophylactic bilateral oophorectomy in a case of colorectal adenocarcinoma with ovarian metastases.

Authors:  E K Shin; B T Takizawa; L Masters; S Shahabi
Journal:  Yale J Biol Med       Date:  2001 Mar-Apr

8.  Clinical analysis of Krukenberg tumours in patients with colorectal cancer-a review of 57 cases.

Authors:  K Y Xu; H Gao; Z J Lian; L Ding; M Li; J Gu
Journal:  World J Surg Oncol       Date:  2017-01-14       Impact factor: 2.754

9.  Bilateral ovarian micrometastatic adenocarcinoma upon prophylactic oophorectomy concurrent with low anterior resection for rectal cancer.

Authors:  Robin Irons; Erin McIntosh; Alexandre Hageboutros; David Warshal; Steven McClane
Journal:  World J Surg Oncol       Date:  2017-02-07       Impact factor: 2.754

10.  Virilisation during Pregnancy in a Patient with Metastatic Colorectal Cancer.

Authors:  F Conway; S Jarvis; M Thornton
Journal:  Case Rep Surg       Date:  2012-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.